Merck Receives FDA Approval for Drug to Treat Rare Lung Condition
Tuesday, 26 March 2024, 21:13
Merck's FDA Approval Breakthrough
The recent FDA approval for Merck's new drug signifies a significant milestone for the company.
Keytruda Market Exclusivity Loss Looms
Keytruda, a blockbuster cancer drug, faces market exclusivity challenges, making diversification crucial for Merck's future.
This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.